SCHEMBL15639701

SCHEMBL15639701

C#CC(C)(C)NC(=O)c1cccnc1Nc1cc(Cl)cc(OC)c1.COc1cc(Cl)cc(Nc2ncccc2C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.55
KMT2A Q03164 10/20 0.55
HTT P42858 2/20 0.55
MAPK1 P28482 2/20 0.55
PKM P14618 1/20 0.55
RAB9A P51151 5/20 0.53
ALDH1A1 P00352 3/20 0.53
NPC1 O15118 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
MAPT P10636 6/20 0.49
DHODH Q02127 8/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 1/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
TOP1 P11387 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15635389 0.96 MEN1 (0.50) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15636276 0.86 MEN1 (0.72) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15638283 0.85 MEN1 (0.48) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15636076 0.85 MEN1 (0.50) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15639323 0.79 GRM4 (0.49) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15636196 0.79 GRM4 (0.49) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15639368 0.79 TOP1 (0.52) MEN1KMT2AHTTMAPK1PKM
SCHEMBL15635050 0.79 MEN1 (0.61) MEN1KMT2AHTTMAPK1PKM
SCHEMBL16638716 0.78 MEN1 (0.58) MEN1KMT2AHTTMAPK1PKM
SCHEMBL17363143 0.78 MEN1 (0.58) MEN1KMT2AHTTMAPK1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903965-A1 N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS Orion Corporation (FI) 2015-08-12 EP disclosed
WO-2014053694-A1 N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS ORION CORPORATION (FI) 2014-04-10 WO disclosed